Giant cell arteritis presenting with chronic cough and headache after BNT162b2 mRNA COVID-19 vaccination.

Ishizuka, Drs K; Katayama, K; Ohira, Y

Ishizuka, Drs K; Katayama, K; Ohira, Y.

Ishizuka DK; Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae, Kawasaki, Kanagawa 216-8511, Japan. email: e103007c@yokohama-cu.ac.jp.
Katayama K; Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae, Kawasaki, Kanagawa 216-8511, Japan.
Ohira Y; Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae, Kawasaki, Kanagawa 216-8511, Japan. email: e103007c@yokohama-cu.ac.jp.

QJM ; 115(9): 621-622, 2022 09 22.

Article in English | MEDLINE | ID: covidwho-1931902

Subject(s)

COVID-19 Vaccines; COVID-19; Giant Cell Arteritis; BNT162 Vaccine; COVID-19 Vaccines/adverse effects; Chronic Disease; Cough/etiology; Giant Cell Arteritis/diagnosis; Headache/etiology; Humans; RNA, Messenger; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Giant Cell Arteritis / COVID-19 Vaccines / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google